Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...

International study finds AI detects pancreatic cancer on CT more accurately than radiologists, offering earlier diagnosis ...

A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has initiated the Phase III ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated the Phase III ...

SOFIE Biosciences, an established U.S. manufacturer and developer of radiopharmaceuticals, today announced that the first patient has been dosed in one of its two Phase 3 clinical trials evaluating ...

Results Underscore PRP Candidacy as a Disruptor of the Tumor MicroenvironmentMELBOURNE, Australia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”) ...

Oncotelic Therapeutics' collaborative study reveals the context-dependent prognostic significance of biomarkers DNMT3A and GMPS in liver and pancreatic cancers, highlighting the importance of tumor ...

Pancreatic ductal adenocarcinoma is a highly aggressive malignancy with a poor prognosis, where accurate prediction of tumor resectability is critical for optimizing treatment strategies. Existing ...

In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of the most ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in metastatic pancreatic cancer. Tumor-treating fields (TTFields) improve overall ...